Some common heterocyclic compound, 109838-85-9, name is (R)-2-Isopropyl-3,6-dimethoxy-2,5-dihydropyrazine, molecular formula is C9H16N2O2, traditional synthetic route has been very mature, but the traditional synthetic route has various shortcomings, such as complicated route, low yield, poor purity, etc, below Introduce a new synthetic route. COA of Formula: C9H16N2O2
DMSO (1.95 g, 1.64 mL, 25.0 mmol) was added dropwise to a solution of oxalyl chloride (1.52 g,1.05 mL, 12.0 mmol) in CH2Cl2 at -78 0C. After stirring at -78 0C for 15 min, 4-phenyl-l-butanol (1.50 g, 1.52 mL, 10.0 mmol) was added dropwise. After 15 min, triethylamine (5.05 g, 6.96 mL) was added dropwise. After warming to r.t. over 2 hours, water (50 mL) was added and the solution was extracted with CH2Cl2 (4 X 50 mL). The combined organic phase was washed with HCl (0.25 N, 3 X 50 mL), water (50 mL), saturated NaHCO3, and brine. The organic extract was dried over Na2SO4, concentrated, and passed through a short silica column (2 x 3 cm), eluted with CH2Cl2. Solvent was removed to give 4-phenylbutanal as a colorless oil (1.30 g, 87percent). 1H NMR (500 MHz, CDCl3) delta 9.76 (t, / = 1.5 Hz, 1 H), 7.31-7.27 (m, 2 H), 7.22-7.17 (m, 2 H), 2.67 (t, / = 7.5 Hz, 2 H), 2.46 (dt, J = 1.6, 7.32 Hz, 2 H), 1.97 (m, 2 H).[000199] To a solution of the bislactim (R)-2-isopropyl-3,6-dimethoxy-2,5-dihydropyrazine (1.842 g, 1.792 mL, 10.0 mmol) in THF (20 mL) at -78 0C was slowly added n-BuLi (6.875 mL, 1.6 M in hexanes, 11.0 mmol) under Ar. After stirring at -78 0C for 20 min, A methyl iodide solution (1.562 g, 0.686 mL, 11.0 mmol) in THF (5 mL) was added. It was stirred at -78 0C for 2 h. A further portion of n-BuLi (6.25 mL, 1.6 M in hexanes, 10.0 mmol) was added at -78 0C and the solution was warmed to 0 0C. A solution of SnCl2 (1.0 g, 5.3 mmol) in THF (20 mL) was added and stirred at 0 0C for 15 min. After cooling to -78 0C, a 4-phenylbutanal solution (0.74 g, 5.0
These compound has a wide range of applications. It is believed that with the continuous development of the source of the synthetic route 109838-85-9, its application will become more common.
Reference:
Patent; FORBES MEDI-TECH (RESEARCH), INC.; WO2008/31032; (2008); A2;,
Pyrazine – Wikipedia,
Pyrazine | C4H4N2 – PubChem